We use cookies for a better user experience. Read our Privacy Policy

I Agree

Brain Biomarkers Market

Brain Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2020 - 2030

Global Brain Biomarkers Market: Overview

Brain biomarkers refer to measurable indicators that are able to make measurement of brain during its diseased state. In the global brain biomarkers market, products and its associated procedures are utilized in the assessment of a disease or health state of a person. Some of the prominent players in the brain biomarkers market are integrating advanced technologies so as to make it easier for physicians and researchers to monitor the condition of the brain via measurement of its molecules.

With such product innovations and advancements, the companies are expected to bring on effective drug development procedure, new options of treatment, rapid diagnosis, and invasive testing of brain. In addition to that, interpretation and detection of the quantities or existence of such biomarkers of brain or its panels can be utilized in the making of patient interventions and clinical decisions. Growing importance of these biomarkers is likely to support growth of the global brain biomarkers market over the timeframe of assessment, from 2020 to 2030.

Product type, disease indication, application, end user, and region are some of the crucial parameters based on which the global brain biomarkers market has been segmented.

Global Brain Biomarkers Market: Notable Developments

The global brain biomarkers market is marked with presence of quite a few prominent players and it is considered moderately competitive market for both the existing players and new entrants. These companies are forging, partnerships, collaborations, and mergers in an effort to gain larger revenue and market share. The following development is expected to play an important role in the market:

  • In May 2020, Swiss healthcare company, F. Hoffmann-La Roche AG, completed its acquisition of American DNA sequencing technology provider, Stratos Genomics. The integration of sequencing by expansion (SBX) chemistry is anticipated to provide the healthcare sector a flexible, fast, and an affordable solution for multiple targeted clinical applications.

Some of the prominent organizations in the global brain biomarkers market comprise the below-mentioned:

  • F. Hoffmann-La Roche AG
  • Advanced Brain Monitoring, Inc.
  • Siemens Healthineers AG
  • NeuroVista Corporation
  • Electrical Geodesics, Inc.
  • Natus Medical Incorporated

Global Brain Biomarkers Market: Key Trends

The global brain biomarkers market is characterized by the presence of the following restraints, drivers, and opportunities.

High Prevalence of Brain Disorders, Especially amongst Geriatric Population, to Drive Demand

The growth of the global brain biomarkers market is estimated to be influenced by several factors prevalent in the market. Presence of a large pool of geriatric population is likely to play an important role for the growth of the market. This particular segment of the human population are prone to have brain disorders, which is they are estimated to drive the demand for brain biomarkers over the period of analysis, from 2020 to 2030. According to the estimates of World Health Organization (WHO), the number of people living with dementia, a very common brain disorder, is expected to rise to 115.4 million by 2050.

In addition, increased investment in the research and development activities so as to come up with better, improved products is likely to augur well for the market. With improved know-how of the nature of neurologic diseases, the demand of brain biomarkers is estimated to rise in the years to come.

Global Brain Biomarkers Market: Geographical Analysis

In terms of region, both Europe and North America are estimated to account for a sizeable chunk of the global brain biomarkers market and the regions are anticipated to remain at the forefront of market growth. Nearly, 100 million people are affected by disorders of brain, such as strokes, Alzheimer’s disease, such high prevalence of disorders is expected to foster growth of the brain biomarkers market in these regions.

Brain Biomarkers Market

Interested in this report?
Get a FREE Brochure now!

Request Brochure

*Get Brochure (PDF) sent to your email within minutes

N/A

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

781

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved